Photodynamic Therapy for Age-Related Macular Degeneration

The Review of Laser Engineering
doi 10.2184/lsj.33.243
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Laser Society of Japan

Related search

Intravitreal Bevacizumab vs Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration

Archives of Ophthalmology
2007English

Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Cohort Study for the UK.

Health Technology Assessment
MedicineHealth Policy
2012English

Comparative Study of Photodynamic Therapy Monotherapy Versus Triplemanagement in Age-Related Macular Degeneration

Turkish Journal of Medical Sciences
Medicine
2014English

Photodynamic Therapy for Age-Related Macular Degeneration in a Clinical Setting: Visual Results and Angiographic Patterns

American Journal of Ophthalmology
Ophthalmology
2004English

Single-Session Photodynamic Therapy Combined With Intravitreal Bevacizumab and Triamcinolone for Neovascular Age-Related Macular Degeneration

BMC Ophthalmology
MedicineOphthalmology
2007English

Changes in Visual Function and Thickness of Macula After Photodynamic Therapy for Age-Related Macular Degeneration

Clinical Ophthalmology
Ophthalmology
2009English

Age-Related Macular Degeneration

2013English

Age Related Macular Degeneration

BMJ
2010English

Age-Related Macular Degeneration

2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy